Devanand Sarkar is a Professor in the Department of Cellular, Molecular and Genetic Medicine at Virginia Commonwealth University. His research focuses on primary liver cancer (hepatocellular carcinoma) and fatty liver disease (metabolic dysfunction-associated steatotic liver disease or MASLD). The laboratory studies molecular mechanisms of these diseases and evaluates novel and targeted treatment strategies using mouse models. His research has been continuously funded by NCI, NIDDK, DOD and other foundations. He is the Associate Director of Cancer Research Training and Education Coordination (CRTEC) of VCU Massey Comprehensive Cancer Center. He co-directs the PhD program in Clinical and Translational Sciences and is the contact PI of a T32 grant funded by NIH/NCATS.